Nexgel Inc
General ticker "NXGL" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $25.4M
Nexgel Inc follows the US Stock Market performance with the rate: 43.4%.
Estimated limits based on current volatility of 3.5%: low 4.57$, high 4.90$
Factors to consider:
- Current price 54.8% above estimated high
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.50$, 3.09$]
- 2024-12-30 to 2025-12-30 estimated range: [1.57$, 3.22$]
Financial Metrics affecting the NXGL estimates:
- Negative: Non-GAAP EPS, $ of -0.56 <= 0.10
- Negative: Operating profit margin, % of -45.96 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -21.28 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Negative: Industry earnings per price (median), % of -6.44 <= 1.31
- Negative: Inventory ratio change, % of 4.42 > 1.08
Short-term NXGL quotes
Long-term NXGL plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $1.55MM | $2.05MM | $4.09MM |
Operating Expenses | $4.12MM | $5.40MM | $7.57MM |
Operating Income | $-2.57MM | $-3.35MM | $-3.48MM |
Non-Operating Income | $-1.60MM | $-1.40MM | $0.29MM |
Interest Expense | $2.00MM | $1.34MM | $0.01MM |
R&D Expense | $0.03MM | $0.37MM | $0.10MM |
Income(Loss) | $-4.17MM | $-4.75MM | $-3.19MM |
Taxes | $0.00MM | $0.00MM | $-0.03MM |
Profit(Loss) | $-4.17MM | $-4.75MM | $-3.16MM |
Stockholders Equity | $12.09MM | $7.64MM | $4.70MM |
Inventory | $0.29MM | $0.50MM | $1.32MM |
Assets | $16.98MM | $10.36MM | $9.96MM |
Operating Cash Flow | $-2.75MM | $-2.99MM | $-3.24MM |
Capital expenditure | $0.27MM | $0.10MM | $0.70MM |
Investing Cash Flow | $-0.27MM | $-5.59MM | $4.46MM |
Financing Cash Flow | $16.34MM | $-3.66MM | $0.38MM |
Earnings Per Share* | $-1.13 | $-1.10 | $-0.56 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.